UPDATE: H.C. Wainwright Downgrades Galmed Pharmaceuticals (GLMD) to Neutral
Tweet Send to a Friend
(Updated - May 3, 2022 6:08 AM EDT)
H.C. Wainwright analyst Ed Arce downgraded Galmed Pharmaceuticals (NASDAQ: GLMD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Ed Arce downgraded Galmed Pharmaceuticals (NASDAQ: GLMD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
